Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-05-13 16:16:49 ET · period of report 2026-05-12 · accession 0001507496-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 16:16 | 2026-05-12 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S - Sale | $79.21 | -459 | 38.3K | -1% | -$36.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-12 | S | D | 459 | $79.21 | 38,271 | D | — | — |